Switch theme
Sign up to access all valuation multiples
Exosens SA is a high-tech company in innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. It offers its customers detection components and solutions such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes. Its products include Night vision tubes, Ultra Violet cameras, Ion and electron detection, Gamma detectors, etc.
2021
1.2K+
LTM Revenue $476M
LTM EBITDA $142M
$2.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Exosens has a last 12-month revenue (LTM) of $476M and a last 12-month EBITDA of $142M.
In the most recent fiscal year, Exosens achieved revenue of $443M and an EBITDA of $129M.
Exosens expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Exosens valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $476M | XXX | $443M | XXX | XXX | XXX |
| Gross Profit | $230M | XXX | $253M | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 57% | XXX | XXX | XXX |
| EBITDA | $142M | XXX | $129M | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 29% | XXX | XXX | XXX |
| EBIT | $108M | XXX | $86.5M | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 20% | XXX | XXX | XXX |
| Net Profit | $56.7M | XXX | $34.5M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Exosens's stock price is EUR 44 (or $49).
Exosens has current market cap of EUR 2.2B (or $2.5B), and EV of EUR 2.1B (or $2.3B).
See Exosens trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.3B | $2.5B | XXX | XXX | XXX | XXX | $1.36 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Exosens has market cap of $2.5B and EV of $2.3B.
Exosens's trades at 5.3x EV/Revenue multiple, and 18.0x EV/EBITDA.
Equity research analysts estimate Exosens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Exosens has a P/E ratio of 43.8x.
See valuation multiples for Exosens and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.5B | XXX | $2.5B | XXX | XXX | XXX |
| EV (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV/Revenue | 4.9x | XXX | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | 16.4x | XXX | 18.0x | XXX | XXX | XXX |
| EV/EBIT | 21.5x | XXX | 26.9x | XXX | XXX | XXX |
| EV/Gross Profit | 10.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 43.8x | XXX | 72.0x | XXX | XXX | XXX |
| EV/FCF | 45.3x | XXX | 21.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialExosens's last 12 month revenue growth is 15%
Exosens's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Exosens's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Exosens's rule of X is 68% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Exosens and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | 29% | XXX | XXX | XXX |
| Rule of 40 | 42% | XXX | 45% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 68% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| ASML | XXX | XXX | XXX | XXX | XXX | XXX |
| Besi | XXX | XXX | XXX | XXX | XXX | XXX |
| Signify | XXX | XXX | XXX | XXX | XXX | XXX |
| Nedap | XXX | XXX | XXX | XXX | XXX | XXX |
| TKH Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Exosens acquired XXX companies to date.
Last acquisition by Exosens was XXXXXXXX, XXXXX XXXXX XXXXXX . Exosens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Exosens founded? | Exosens was founded in 2021. |
| Where is Exosens headquartered? | Exosens is headquartered in France. |
| How many employees does Exosens have? | As of today, Exosens has 1.2K+ employees. |
| Is Exosens publicy listed? | Yes, Exosens is a public company listed on PAR. |
| What is the stock symbol of Exosens? | Exosens trades under EXENS ticker. |
| When did Exosens go public? | Exosens went public in 2024. |
| Who are competitors of Exosens? | Similar companies to Exosens include e.g. ASML, Besi, Signify, Nedap. |
| What is the current market cap of Exosens? | Exosens's current market cap is $2.5B |
| What is the current revenue of Exosens? | Exosens's last 12 months revenue is $476M. |
| What is the current revenue growth of Exosens? | Exosens revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Exosens? | Current revenue multiple of Exosens is 4.9x. |
| Is Exosens profitable? | Yes, Exosens is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Exosens? | Exosens's last 12 months EBITDA is $142M. |
| What is Exosens's EBITDA margin? | Exosens's last 12 months EBITDA margin is 30%. |
| What is the current EV/EBITDA multiple of Exosens? | Current EBITDA multiple of Exosens is 16.4x. |
| What is the current FCF of Exosens? | Exosens's last 12 months FCF is $51.4M. |
| What is Exosens's FCF margin? | Exosens's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Exosens? | Current FCF multiple of Exosens is 45.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
